SIG
Sargent Investment Group Portfolio holdings
AUM
$740M
This Quarter Return
+9.06%
1 Year Return
+41.44%
3 Year Return
+107.47%
5 Year Return
+182.16%
10 Year Return
–
AUM
$412M
AUM Growth
+$412M
(+8.5%)
Cap. Flow
+$7.24M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
35.98%
Holding
211
New
14
Increased
96
Reduced
72
Closed
12
Top Buys
| 1 |
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
$5.09M |
| 2 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
$1.35M |
| 3 |
Energy Recovery
ERII
|
$1.04M |
| 4 |
AKTS
AKOUSTIS TECHNOLOGIES, INC.
AKTS
|
$874K |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$782K |
Top Sells
| 1 |
Apple
AAPL
|
$1.73M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$1.28M |
| 3 |
Iron Mountain
IRM
|
$1.17M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
$845K |
| 5 |
Blackstone
BX
|
$658K |
Sector Composition
| 1 | Technology | 27.83% |
| 2 | Financials | 10.59% |
| 3 | Healthcare | 10.29% |
| 4 | Industrials | 7.03% |
| 5 | Consumer Discretionary | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
176
Saul Centers
BFS
$813M
| $222K | 0.05% |
6,025
| – | – |
|
177
Williams Companies
WMB
$70.5B
| $221K | 0.05% |
+6,780
| New | +$221K |
|
178
Las Vegas Sands
LVS
$38B
| $211K | 0.05% |
3,635
+20
| +0.6% | +$1.16K |
|
179
iShares MSCI EAFE ETF
EFA
$65.4B
| $211K | 0.05% |
2,905
-265
| -8% | -$19.2K |
|
180
Novo Nordisk
NVO
$252B
| $210K | 0.05% |
1,300
| – | – |
|
181
Southern Company
SO
$101B
| $209K | 0.05% |
+2,980
| New | +$209K |
|
182
Huntington Ingalls Industries
HII
$10.6B
| $208K | 0.05% |
+915
| New | +$208K |
|
183
Apollo Global Management
APO
$75.9B
| $206K | 0.05% |
+2,680
| New | +$206K |
|
184
Nucor
NUE
$33.3B
| $204K | 0.05% |
+1,247
| New | +$204K |
|
185
Vanguard S&P 500 ETF
VOO
$724B
| $204K | 0.05% |
+500
| New | +$204K |
|
|
CBIO
186
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $188K | 0.05% |
108,000
| – | – |
|
187
Tarsus Pharmaceuticals
TARS
$2.44B
| $182K | 0.04% |
10,045
-534
| -5% | -$9.65K |
|
188
Cohen & Steers Closed End Opportunity Fund
FOF
$361M
| $162K | 0.04% |
15,085
| – | – |
|
|
THW
189
abrdn World Healthcare Fund
THW
$477M
| $140K | 0.03% |
10,000
-10,000
| -50% | -$140K |
|
190
Ardelyx
ARDX
$1.57B
| $122K | 0.03% |
35,937
+1,986
| +6% | +$6.73K |
|
191
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $84.1K | 0.02% |
+19,692
| New | +$84.1K |
|
|
BLUE
192
DELISTED
bluebird bio
BLUE
| $80K | 0.02% |
+24,324
| New | +$80K |
|
193
SiriusXM
SIRI
$7.92B
| $77.3K | 0.02% |
17,073
-2,027
| -11% | -$9.2K |
|
194
Athira Pharma
ATHA
$15.5M
| $61.5K | 0.01% |
20,833
+561
| +3% | +$1.66K |
|
|
INTZ
195
DELISTED
INTRUSION INC NEW
INTZ
| $40.8K | 0.01% |
33,405
+2,950
| +10% | +$3.6K |
|
196
Relmada Therapeutics
RLMD
$48.8M
| $40.6K | 0.01% |
16,506
+2,189
| +15% | +$5.39K |
|
|
TELL
197
DELISTED
Tellurian Inc.
TELL
| $32.4K | 0.01% |
23,000
+3,000
| +15% | +$4.23K |
|
198
Summit Therapeutics
SMMT
$17.5B
| $25.1K | 0.01% |
+10,000
| New | +$25.1K |
|
199
Taysha Gene Therapies
TSHA
$791M
| $16.9K | ﹤0.01% |
25,634
+6,065
| +31% | +$4.01K |
|
200
Vanguard Russell 3000 ETF
VTHR
$3.52B
| – | – |
-1,105
| Closed | -$203K |
|